Humacyte Insider Trades
NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $90.21K
- Sales
- 2 · $82.29K
- Shares bought / sold
- 117.82K / 91.77K
- Net activity
- Net buying $7,916
Humacyte insider activity
Over the last 12 months, Humacyte insiders reported 9 transactions on SEC Form 4: 5 open-market purchases and 2 sales. Insiders bought $90,209 and sold $82,294 worth of stock, for net insider buying of $7,916. The largest seller was Parikh Shamik J, with $41,147 in reported sales.
The most recent filing shows Jones Keith Anthony (Director) buying 10,000 shares at $0.562 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HUMA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
HUMA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 14, 2026 | Jones Keith AnthonyDirector | Buy | 10,000 | $5.62K | Form 4 |
| Aug 20, 2026 | Jones Keith AnthonyDirector | Buy | 10,000 | $6.93K | Form 4 |
| Aug 17, 2026 | Jones Keith AnthonyDirector | Buy | 30,000 | $17.82K | Form 4 |
| May 19, 2026 | Sebelius KathleenDirector | Buy | 56,818 | $50.00K | Form 4 |
| May 18, 2026 | Parikh Shamik JChief Medical Officer | Sale | 45,887 | $41.15K | Form 4 |
| May 18, 2026 | Sander Dale A.CFO and Chief Corp. Dev. Off | Sale | 45,887 | $41.15K | Form 4 |
| May 18, 2026 | Constantino Michael T.Director | Buy | 11,000 | $9.84K | Form 4 |
| Nov 16, 2025 | Sander Dale A.CFO and Chief Corp. Deve. Off. | Award | 311,100 | — | Form 4 |
| Nov 16, 2025 | Parikh Shamik JChief Medical Officer | Award | 311,100 | — | Form 4 |
| Aug 20, 2025 | Niklason Laura EPresident, CEO and Director | Sale | 591,685 | $934.86K | Form 4 |
| Aug 20, 2025 | Dougan Brady WDirector | Sale | 591,685 | $934.86K | Form 4 |
| Aug 19, 2025 | Niklason Laura EPresident, CEO and Director | Sale | 1,100,000 | $1.79M | Form 4 |
| Aug 19, 2025 | Dougan Brady WDirector | Sale | 1,100,000 | $1.79M | Form 4 |
| Aug 18, 2025 | Niklason Laura EPresident, CEO and Director | Sale | 549,360 | $1.01M | Form 4 |
| Aug 18, 2025 | Dougan Brady WDirector | Sale | 549,360 | $1.01M | Form 4 |
| Apr 14, 2025 | Scheessele William JohnChief Commercial Officer | Buy | 6,493 | $10.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4